Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Tryptamine Therapeutics ( (AU:TYP) ) has shared an update.
Tryptamine Therapeutics Limited has released its corporate governance statement for the financial year ending June 30, 2025, which has been approved by the board and is available on their website. The statement outlines the company’s adherence to the ASX Corporate Governance Council’s recommendations, detailing the roles and responsibilities of the board and management, and the processes followed for director appointments and accountability, reflecting the company’s commitment to transparency and regulatory compliance.
More about Tryptamine Therapeutics
Average Trading Volume: 1,585,657
Technical Sentiment Signal: Sell
Current Market Cap: A$47.5M
Find detailed analytics on TYP stock on TipRanks’ Stock Analysis page.